Reacting to the news that more Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care to cover HRT products, Professor Claire Anderson, President of the Royal Pharmaceutical Society, said:
“We welcome the news that more SSPs have been put in place for hormone replacement therapy products. This short term measure will help women access supplies of HRT medicines which are difficult to get hold of.
“This is a very fluid situation with some products due to return to normal availability shortly.
“However, the bureaucracy involved in completing the SSP process for each individual patient is quite burdensome for pharmacists and we hope to see the shortage of HRT products resolved as soon as possible under the leadership of the new HRT Czar. Ultimately we’d like to see a change in the law which makes the whole process easier and quicker for both pharmacists and patients.
“The advice on which HRT product to substitute with another has been drawn up by experts and women can be confident they will receive what’s appropriate for them. Women should talk to their pharmacist if they have any concerns about their HRT medicines.”
SSP update on NHS BSA site
Read more RPS News
Want the latest pharmacy news and updates straight to your inbox?
Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.
Sign Up